secwatch.observer — SEC 8-K summary
======================================

Issuer:     Molecular Templates, Inc. (—)
CIK:        0001183765
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001193125-24-069133
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

BMS terminates ETB collaboration with Molecular Templates; termination effective June 13, 2024
--------------------------------------------------------------------------------

- BMS notified Molecular Templates on March 13, 2024 of intent to terminate the Collaboration Agreement entered in February 2021.
- Termination becomes effective June 13, 2024; company will reduce costs and focus resources on wholly-owned clinical-stage programs.
- Collaboration leveraged Molecular Templates' ETB platform for novel products; BMS cited portfolio prioritization.
- Molecular Templates will no longer receive research support from BMS under the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1183765/000119312524069133/0001193125-24-069133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1183765/000119312524069133/d813216d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-069133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer